CytRx Corp said its 60 pct owned CytRxBiopool Ltd subsidiary has acquired Biopool AB of Umea, Sweden,for undisclosed terms.    It said former shareholders of Biopool AB own the remaining40 pct in CytRx Biopool Ltd. Biopool AB develops cardiovascularand fibrinolytic products for diagnostic applications.    The company said CytRx Biopool is studying the possiblecombination of CytRx Corp's RheothRx drug to reduce plateletaggregation and viscosity in blood with Biopool AB's drug t-PAfor dissolving blood clots. Reuter&#3;